U.S. Communications Stock News

NasdaqGS:AOSL
NasdaqGS:AOSLSemiconductor

Alpha and Omega Semiconductor (AOSL): Evaluating Valuation After Strong Power IC Growth and Joint Venture Sale in Q1 2026

Alpha and Omega Semiconductor (AOSL) drew fresh attention after releasing its fiscal Q1 2026 results, which included impressive growth in Power IC revenue as well as the completion of a joint venture equity sale in China. See our latest analysis for Alpha and Omega Semiconductor. It has been a volatile stretch for Alpha and Omega Semiconductor. After management’s cautious guidance and a high-profile analyst downgrade, the stock’s share price plunged 27.6% over the past week and is now down...
NasdaqGS:STKL
NasdaqGS:STKLFood

SunOpta (STKL): Valuation Perspectives After Upside Sales Surprise and Margin Pressures

SunOpta (STKL) just reported its latest quarterly results, showing revenue growth that topped expectations and lifting its full-year sales guidance. Investors, however, are debating what comes next as margins moved lower. See our latest analysis for SunOpta. After SunOpta surprised with stronger quarterly sales and a raised outlook, the share price has been on a wild ride, tumbling nearly 24% over the past week and down 45.5% in total shareholder return over the last year. While management’s...
NasdaqGS:BMBL
NasdaqGS:BMBLInteractive Media and Services

Bumble (BMBL): Evaluating Valuation After Weak Q3 Results and Pessimistic Guidance

Bumble (BMBL) shares dropped sharply after the company announced third-quarter results, featuring a 16% fall in paying users and a 10% drop in revenue from the prior year. The company also issued cautious guidance for the upcoming quarter. See our latest analysis for Bumble. Bumble’s share price has tumbled over 46% year-to-date and is down 47% on a total return basis over the last year, as investors reacted to weaker guidance and ongoing declines in paying users. While recent news about a...
NasdaqCM:ALTO
NasdaqCM:ALTOChemicals

Alto Ingredients (ALTO): Evaluating Valuation Following Surprise Third Quarter Return to Profit

Alto Ingredients (ALTO) surprised many investors by swinging back to profitability in its third quarter earnings report. Despite lower sales compared to last year, the company posted a solid net income and turned around from a loss during the same period in 2024. See our latest analysis for Alto Ingredients. Alto Ingredients’ third quarter turnaround has given new life to its recent momentum, with a remarkable 7-day share price return of 36.63% and a 1-month share price gain of 23.21%...
NYSE:ASPN
NYSE:ASPNChemicals

Why Aspen Aerogels (ASPN) Is Down 52.6% After Slashing Guidance and Taking a Major Impairment Charge

Aspen Aerogels recently reported third quarter 2025 financial results that included a sharp year-over-year drop in revenue to US$73.02 million and a net loss of US$6.33 million, while revising full-year 2025 guidance downward due to continuing challenges in the electric vehicle market. The company incurred a very large impairment charge on property, plant, and equipment and announced new leadership appointments to address sector headwinds and operational efficiency, signaling a pivot toward...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Veracyte Shares Surge 20% as Analyst Upgrades Spark Fresh Valuation Debate

Wondering if Veracyte is offering real value right now? You're not alone, and with so much movement in health tech stocks, this could be a good moment to take a closer look. Veracyte shares have rallied recently, jumping 15.6% in the last week and up 19.8% for the past month, easily outpacing the broader market. The buzz isn't just about the price. A series of positive research collaborations and analyst upgrades are turning heads, giving fresh context to the recent...
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

What Recent Supply Chain Wins Could Mean for Power Solutions International’s Share Price in 2025

If you have ever wondered whether Power Solutions International could be one of the market’s best kept secrets or simply overpriced, you are not alone. Let’s dive in together and find out what’s really driving its value. Despite powering ahead with 134.6% gains over the past year (and an eye-popping 3653.7% rise over three years), the stock has pulled back sharply, dropping 23.3% in just the last week. Recent headlines have brought attention to supply chain improvements and new large-scale...
NasdaqGS:GDRX
NasdaqGS:GDRXHealthcare Services

GoodRx (GDRX): A Fresh Look at Valuation After Recent Share Price Decline

GoodRx Holdings (GDRX) has seen its stock under pressure lately, with a 29% drop over the past month. Investors are considering the company’s performance as they assess how recent trends in the healthcare discount space could impact future results. See our latest analysis for GoodRx Holdings. After a rocky few months, GoodRx Holdings’ downward momentum is hard to ignore. Despite brief rallies, the share price return year-to-date is down nearly 32%, and the one-year total shareholder return...
NasdaqGM:CCLD
NasdaqGM:CCLDHealthcare Services

CareCloud (CCLD): Evaluating Valuation After Recent 17% Share Price Jump

CareCloud (CCLD) shares have shown steady movement lately, with investors weighing recent performance trends. Over the past week, returns saw a sharp increase of 17%. In addition, the past 3 months delivered solid gains overall. See our latest analysis for CareCloud. Zooming out, CareCloud has seen momentum shift in recent months, with a 17% share price return over the past week helping to recover ground lost earlier in the year. Even so, the stock’s one-year total shareholder return sits at...
NYSE:INFA
NYSE:INFASoftware

Informatica (INFA): Assessing Valuation as Fundamentals and Market Sentiment Shift

Informatica (INFA) has been drawing some attention lately, as investors weigh its recent performance and underlying fundamentals. With a year-to-date return slightly negative and modest revenue growth, there is fresh debate about how the stock stacks up in the software sector. See our latest analysis for Informatica. Looking at the bigger picture, Informatica’s share price has drifted lower in recent months, reflecting a cautious mood after a period of modest gains. Despite this, its...
NasdaqGS:OMDA
NasdaqGS:OMDAHealthcare

Omada Health (OMDA): Is the Stock Overvalued After Recent Volatility?

Omada Health (OMDA) has been the subject of some investor attention lately. It is worth taking a closer look at how the company's stock has performed in the past month and what might be driving sentiment. See our latest analysis for Omada Health. Omada Health’s share price return has been volatile lately, dropping 17.3% over the last week alone and down 15.3% for the month, even as it remains up for the past quarter. Momentum appears to have faded in the short term, hinting at shifting...
NYSE:OPTU
NYSE:OPTUMedia

Optimum Communications (ATUS): Examining Valuation as Share Price Stabilizes After Steep Declines

Optimum Communications (NYSE:ATUS) shares saw subtle movement this week, offering investors fresh perspective on the company’s current valuation. With performance figures in hand, a closer inspection can reveal trends that may impact future expectations. See our latest analysis for Optimum Communications. After a period of sharp declines, Optimum Communications’ share price has shown only modest swings lately, even as the company navigates a shifting media landscape and ongoing operational...
NYSE:CTEV
NYSE:CTEVHealthcare Services

Claritev (CTEV): Assessing Valuation Following Upbeat Earnings and Raised Revenue Guidance

Claritev (NYSE:CTEV) is in focus after announcing improved third-quarter results and raising full-year revenue guidance. The company reported stronger sales and sharply reduced losses, which signals momentum building into the second half of 2025. See our latest analysis for Claritev. The rally in Claritev’s stock has been hard to ignore; the share price closed at $69.25 after a one-day gain of 11.77%. The company now boasts a staggering year-to-date price return of 434.75%. These moves follow...